PK and Tolerability of IV and Oral CK-1827452 in Patients With Ischemic Cardiomyopathy and Angina
Status:
Completed
Trial end date:
2009-03-01
Target enrollment:
Participant gender:
Summary
This study investigates whether symptom-limited exercise capacity in ischemic cardiomyopathy
patients with angina is deleteriously affected by treatment with CK-1827452.